Literature DB >> 25399385

Distinguishing gouty arthritis from calcium pyrophosphate disease and other arthritides.

Christian Löffler1, Horst Sattler2, Lena Peters2, Uta Löffler2, Michael Uppenkamp2, Raoul Bergner2.   

Abstract

OBJECTIVE: Differentiating gout, calcium pyrophosphate deposition disease (CPPD), and non-crystal-related inflammatory arthropathies (non-CRA) is essential but often clinically impossible. The sonographic double contour (DC) sign may have good specificity for gout in highly specialized centers, but it can be challenging to use it to distinguish gout from cartilage hyperenhancements in CPPD. We evaluated the diagnostic value of the DC sign alone and in combination with Doppler signals and uric acid (UA) levels in patients with acute arthritis.
METHODS: We retrospectively investigated 225 acutely inflamed joints and documented the presence of DC, Doppler hypervascularization, and serum UA (SUA) levels. All patients underwent synovial fluid (SF) analysis. Sensitivity, specificity, and positive predictive values were calculated, and correlation analyses and a binary regression model were used to investigate their diagnostic values.
RESULTS: The sensitivity of DC sign for crystalline arthritides was 85% and specificity 80%. Its specificity for gout was 64%, for CPPD 52%. In contrast to non-CRA hypervascularization, degree 2 and 3 Doppler signals were highly associated with gout and less with CPPD (p < 0.01). The combination of DC sign with hypervascularization and elevated UA levels increased specificity for gout to more than 90% and resulted in a 7-fold increase of the likelihood of diagnosis of gout (p < 0.01), but with a loss of sensitivity (42%).
CONCLUSION: The DC sign alone is suitable for predicting crystal-related arthropathies, but it cannot reliably distinguish gout from CPPD in everyday clinical routine. Combining hypervascularization and SUA levels increases the diagnostic value, leading us to propose a diagnostic algorithm.

Entities:  

Keywords:  CPPD; DOPPLER; DOUBLE CONTOUR; GOUT; HYPERVASCULARIZATION; SONOGRAPHY

Mesh:

Substances:

Year:  2014        PMID: 25399385     DOI: 10.3899/jrheum.140634

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  19 in total

Review 1.  Gout - a guide for the general and acute physicians.

Authors:  Abhishek Abhishek; Edward Roddy; Michael Doherty
Journal:  Clin Med (Lond)       Date:  2017-02       Impact factor: 2.659

Review 2.  Calcium Pyrophosphate Deposition Disease.

Authors:  Ann K Rosenthal; Lawrence M Ryan
Journal:  N Engl J Med       Date:  2016-06-30       Impact factor: 91.245

3.  Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard.

Authors:  Alexis Ogdie; William J Taylor; Tuhina Neogi; Jaap Fransen; Tim L Jansen; H Ralph Schumacher; Worawit Louthrenoo; Janitzia Vazquez-Mellado; Maxim Eliseev; Geraldine McCarthy; Lisa K Stamp; Fernando Perez-Ruiz; Francisca Sivera; Hang-Korng Ea; Martijn Gerritsen; Giovanni Cagnotto; Lorenzo Cavagna; Chingtsai Lin; Yin-Yi Chou; Anne-Kathrin Tausche; Manuella Lima Gomes Ochtrop; Matthijs Janssen; Jiunn-Horng Chen; Ole Slot; Juris Lazovskis; Douglas White; Marco A Cimmino; Till Uhlig; Nicola Dalbeth
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

4.  Value of ultrasonography in the diagnosis of gout in patients presenting with acute arthritis.

Authors:  Nuttaya Pattamapaspong; Withawat Vuthiwong; Thanat Kanthawang; Worawit Louthrenoo
Journal:  Skeletal Radiol       Date:  2017-03-08       Impact factor: 2.199

Review 5.  Utility of Ultrasound and Dual Energy CT in Crystal Disease Diagnosis and Management.

Authors:  Georgios Filippou; Tristan Pascart; Annamaria Iagnocco
Journal:  Curr Rheumatol Rep       Date:  2020-04-15       Impact factor: 4.592

6.  Size matters: observations regarding the sonographic double contour sign in different joint sizes in acute gouty arthritis.

Authors:  C Löffler; H Sattler; U Löffler; B K Krämer; R Bergner
Journal:  Z Rheumatol       Date:  2018-11       Impact factor: 1.372

7.  An investigation of the independent risk factors that differentiate gout from pseudogout in patients with crystal-induced acute arthritis: a cross-sectional study.

Authors:  Chayawee Muangchan; Thitirat Bhurihirun
Journal:  Rheumatol Int       Date:  2017-12-06       Impact factor: 2.631

8.  Managing Gout Flares in the Elderly: Practical Considerations.

Authors:  Abhishek Abhishek
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

Review 9.  Imaging of calcium pyrophosphate deposition disease.

Authors:  Jennifer Miksanek; Ann K Rosenthal
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

10.  How to Differentiate Gout, Calcium Pyrophosphate Deposition Disease, and Osteoarthritis Using Just Four Clinical Parameters.

Authors:  Dmitrij Kravchenko; Raoul Bergner; Charlotte Behning; Valentin Sebastian Schäfer
Journal:  Diagnostics (Basel)       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.